News
1 October 2026
Fonko Strengthens Indonesia’s Oncology Industry Capacity
JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of "first copy" products for cancer therapy, and obtaining halal certification for its…
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
26 March 2021
Dexa Award Science Scholarship 2021: Indonesia Needs More Health Scientist
Indonesia needs more scientist in the health sector to address various health problems, especially related to the Covid-19 pandemic. For information, the total number of researchers in Indonesia is still minimal. According to the 2017-2045 National Research Master Plan, currently, there are only 80 researchers per 1 million population, while…
23 March 2021
PIT PDHMI: Indonesia Indigenous Modern Medicine Proven Preclinically and Clinically for Disease Treatment
Indonesia Indigenous Modern Medicine (OMAI) has been proven preclinically and clinically for the treatment or therapy of disease. At the 2021 Indonesian Medical Herbal Medicine Association Annual Scientific Meeting (PIT PDHMI), scientists and also health practitioners agreed that OMAI could be used for the treatment of patients. "The doctors they…
16 February 2021
Dr. Raymond Tjandrawinata: Boost Immunity with Immunomodulators Original Indonesian Modern Medicines
Farid Nila Moeloek (FNM) Society held a webinar entitled "Use of Herbs to Increase Immunity in the COVID-19 Pandemic". The discussion, which was attended by experts in the health sector, concluded that it was time for Indonesian Original Modern Medicine (OMAI) to be included in the medical education curriculum. "How…
26 January 2021
Dexa Group Scoops Indonesia Public Relations Award 2021
Dexa Group received another award for its Corporate Public Relations performance at the Indonesia Corporate PR Award (IPRA) 2020 in The Best Public Relations in Healthcare & Pharmaceuticals category. This is the third IPRA award Dexa Group has collected since 2018. This award was presented virtually by the CEO of…
18 December 2020
Dexa Group CEO Named as Most Admired CEO 2020 for Ensuring Innovation in the Midst of Crisis
Dexa Group CEO, Ferry Soetikno won the Most Admired CEO 2020 award themed “The Rise of New Leadership Era to Accelerate Recovery” in the category of Outstanding Leadership for World-Class Pharmaceutical Company in Developing Health Sector Innovation to Survive During Crisis from WartaEkonomi.co.id Research and Consulting. This award applauds the…
10 November 2020
Dexa Medica Granted Highest Award for Innovation, President Jokowi: Indonesia Needs Health Innovators
Dexa Group, through PT Dexa Medica, won the 2020 Innovative Industry Award from the Ministry of Research and Technology/National Research and Innovation Agency (Kemenristek/BRIN). The award was given for Dexa Group’s commitment to developing Native Indonesian Modern Medicine (OMAI). The 2020 Innovative Industry Award was opened with remarks from President…
22 July 2020
Dexa Group Receives Award from LPPOM MUI for Consistently Implementing Halal Assurance System
Dexa Group was awarded by the Assessment Institute for Foods, Drugs, and Cosmetics Indonesian Council of Ulama (LPPOM-MUI) as one of the pioneers of halal products which consistently implement an excellent Halal Assurance System in the Medicines & Supplements category. The award was presented directly by the Deputy Director of…